Cyberfort Software, Inc. (CYBF) Negotiating Just Content

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
383
Cyberfort Software, Inc. (CYBF) Negotiating Just Content Software Purchase Agreement, Other Updates Announced

- Cyberfort is negotiating the purchase of Just Content Software, the company announced in a near-term corporate objectives update
- The company will also working toward upgrading its Vivio ad blocking app to enhance its functionalities and guarantee an even higher level of device efficiency
- Increased focus on more effective social media communication was also announced, alongside a decision to uplist to the OTCQB Venture Market

Cyberfort Software, Inc. (OTC: CYBF) recently issued an update on near-term corporate objectives (http://nnw.fm/9jldD). One of them is the negotiation of a purchase agreement to acquire Just Content Software, a multi-platform solution for content filtering and ad blocking. The acquisition will assist Cyberfort in the development of new solutions aimed at addressing some of the most common contemporary cybersecurity threats.

“As Cyberfort Software continues to focus on transparency and accelerated growth, we want to keep shareholders abreast with our new plans and solutions”, CEO Daniel Cattlin stated in a news release. “Each of the goals listed in the update is at a specific stage of development and additional information about progress will be provided in the future.”

Upon the acquisition of Just Content, Cyberfort plans to update its software in order to deliver seamless integration with the new iOS 12 and OS X Mojave. The move will enable the company to improve on the current development and expand its existing functionalities. The Just Content App utilizes a proprietary Home Safe Filter and Business Filter, which provide protection from unsafe links, phishing attempts, adult content and inflammatory hate speech.

Cyberfort will also be rebranding and updating its Vivio app. Vivio is an ad blocking solution that reduces data traffic on iOS devices. Through the update, Vivio will feature a new operating code that enables a better web experience. This new code will, among other things, allow users to create their own personalized whitelists or choose one of the lists developed by the Cyberfort team. Currently, Vivio saves 38 percent of data traffic and reduces the resource load on a device by 58 percent.

Cyberfort Software also announced expansion of its social media communications strategy. The company will be launching its Facebook and Twitter accounts to interact more effectively with customers and provide information about common online dangers and how to safeguard privacy. Through these platforms, Cyberfort also hopes to collect real-time feedback about the customer experience.

The final near-term corporate objectives announcement is Cyberfort’s decision to uplist to the OTCQB Venture Market. The move represents an important milestone for both the company and its shareholders. Through the uplisting, Cyberfort will ensure a higher level of transparency and much broader exposure to investing audiences. To fulfill the OTCQB requirements, the company will complete an annual verification and management certification. A full financial audit will also be carried out.

Cyberfort Software specializes in the acquisition and development of cybersecurity, ad blocking and content filtering solutions. The company’s portfolio is designed to help tackle various online threats through the development of innovative protection technologies usable across different devices.

For more information, visit the company’s website at www.CyberfortSoftware.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Medical Cannabis Payment Solutions (REFG) Stock Research Links

REFG Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 221

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 79

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 189

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 85

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 129

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 389

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 0

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 159

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading

Top 5 Most Recently Viewed Articles

Vor Bio's Exploration of Strategic Alternatives for Growth

Updated Category News Views 213

Vor Bio Announces Exploration of Strategic Alternatives Today, Vor Bio, a clinical-stage cell and genome engineering company, has taken significant steps to enhance shareholder value. The decision comes at a time when the clinical data from its major programs suggests that reevaluating its approach could be beneficial in the face of challenging fundraising conditions....

Continue Reading
Kraig Biocraft Achieves Record Production in Spider Silk Fibers

Updated Category News Views 56

Kraig Biocraft Laboratories' Milestone in Spider Silk Production Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB), a pioneering firm renowned for its innovative developments in spider silk-based fibers, is thrilled to share the successful conclusion of its fourth production cycle for the year. This cycle represents a remarkable achievement, showcasing record-breaking...

Continue Reading
Gen X Faces Retirement Challenges: Understanding the Crisis

Updated Category News Views 282

Gen X’s Coming Retirement Crunch Gen X—often called the “sandwich generation”—is being pulled in two directions at once and edging toward a retirement problem many don’t fully see. With money, time, and attention split between family and work, long-term savings can drift to the back burner. The worry isn’t abstract; it’s about whether the money will be...

Continue Reading
Luxurious Villa Spectre: A $55 Million Icon of Elegance

Updated Category News Views 342

Villa Spectre: A $55 Million Marvel of Luxury Living Villa Spectre has recently captured the spotlight as the highest-priced sale in the area, setting a remarkable benchmark in luxury real estate. This impressive estate was sold for $55,000,000, showcasing the allure and opulence that the elite have come to expect from high-end properties. A Visionary Creation Designed by...

Continue Reading
Mosaic Minerals Shifts Focus to Gold with Amanda Acquisition

Updated Category News Views 333

Mosaic Minerals Re-prioritizes Focus on Gold Exploration Mosaic Minerals Corporation (CSE: MOC) is making a strategic pivot in its exploration efforts. The company has announced the cessation of its lithium exploration initiatives, particularly those in Jamésie, Quebec. Instead, Mosaic is setting its sights on more promising ventures in gold and nickel, specifically...

Continue Reading